_id
69148b18ccc777a4e85d9963
Ticker
PCSA
Name
Processa Pharmaceuticals Inc
Exchange
NASDAQ
Address
7380 Coca Cola Drive, Hanover, MD, United States, 21076
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.processapharmaceuticals.com
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical trials to treat pancreatic, biliary tract, lung, ovarian, breast, and other cancers; Capecitabine, a combination of PCS6422 and capecitabine, which is in Phase 2 clinical trials to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; and Irinotecan, PCS11T that is in pre-clinical studies to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. It also develops non-oncology drugs consisting of PCS12852 that is in Phase 2B clinical trials for treatment of gastroparesis; and PCS499 for the treatment of glomerular disease. The company has license agreements with Elion Oncology, Inc.; Ocuphire Pharma, Inc.; Aposense, Ltd.; Yuhan Corporation; and CoNCERT Pharmaceuticals, Inc. Processa Pharmaceuticals, Inc. was founded in 2017 and is based in Hanover, Maryland.
Last Close
3.07
Volume
227969
Current Price
3.14
Change
0.3
Last Updated
2026-01-06T08:58:29.913Z
Image
data:image/webp;base64,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
Ipo Date
2017-10-10T00:00:00.000Z
Market Cap
7318430
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.882
Sentiment Sources
3
Rating
3
Target Price
25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3488843
Operating Income
-3488843
Interest Expense
-
Pretax Income
-3436573
Net Income
-3436573
Eps
-1.8077512031692444
Dividends Per Share
-
Shares Outstanding
2265768
Income Tax Expense
-
EBITDA
-3436272
Operating Margin
-
Total Other Income Expense Net
52270
Cash
6308420
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
6586762
Property Plant Equipment
4113
Total Assets
7584576
Payables
727172
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1750978
Equity
5833598
Bs_currency_symbol
USD
Depreciation
301
Change In Working Capital
-375457
Cash From Operations
-3484364
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2856164
Net Change In Cash
-628200
Cf_currency_symbol
USD
PE
-
PB
1.0232460207234026
ROE
-58.9100071688176
ROA
-45.31002128530323
FCF
-3484364
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3488843
Quarters > 0 > income Statement > operating Income
-3488843
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3436573
Quarters > 0 > income Statement > net Income
-3436573
Quarters > 0 > income Statement > eps
-1.8077512031692444
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1901021
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3436272
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
52270
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6308420
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
6586762
Quarters > 0 > balance Sheet > property Plant Equipment
4113
Quarters > 0 > balance Sheet > total Assets
7584576
Quarters > 0 > balance Sheet > payables
727172
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1750978
Quarters > 0 > balance Sheet > equity
5833598
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3436573
Quarters > 0 > cash Flow > depreciation
301
Quarters > 0 > cash Flow > change In Working Capital
-375457
Quarters > 0 > cash Flow > cash From Operations
-3484364
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2856164
Quarters > 0 > cash Flow > net Change In Cash
-628200
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.8077512031692444
Quarters > 0 > ratios > PB
1.0232460207234026
Quarters > 0 > ratios > ROE
-58.9100071688176
Quarters > 0 > ratios > ROA
-45.31002128530323
Quarters > 0 > ratios > FCF
-3484364
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
301
Quarters > 1 > income Statement > gross Profit
-301
Quarters > 1 > income Statement > operating Expenses
3950783
Quarters > 1 > income Statement > operating Income
-3950783
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3933918
Quarters > 1 > income Statement > net Income
-3933918
Quarters > 1 > income Statement > eps
-6.316786881876514
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
622772
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3950482
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
16865
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6936620
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7153821
Quarters > 1 > balance Sheet > property Plant Equipment
28732
Quarters > 1 > balance Sheet > total Assets
8181789
Quarters > 1 > balance Sheet > payables
785754
Quarters > 1 > balance Sheet > short Term Debt
25584
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2074581
Quarters > 1 > balance Sheet > equity
6107208
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3933918
Quarters > 1 > cash Flow > depreciation
301
Quarters > 1 > cash Flow > change In Working Capital
1436542
Quarters > 1 > cash Flow > cash From Operations
-2270405
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
6309953
Quarters > 1 > cash Flow > net Change In Cash
4039548
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-6.316786881876514
Quarters > 1 > ratios > PB
0.3201960830546463
Quarters > 1 > ratios > ROE
-64.41434449260612
Quarters > 1 > ratios > ROA
-48.08139149029632
Quarters > 1 > ratios > FCF
-2270405
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
301
Quarters > 2 > income Statement > gross Profit
-301
Quarters > 2 > income Statement > operating Expenses
2846990
Quarters > 2 > income Statement > operating Income
-2846990
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2834405
Quarters > 2 > income Statement > net Income
-2834405
Quarters > 2 > income Statement > eps
-7.437977600033589
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
381072
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2846689
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
12585
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2897072
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3757886
Quarters > 2 > balance Sheet > property Plant Equipment
52452
Quarters > 2 > balance Sheet > total Assets
4809574
Quarters > 2 > balance Sheet > payables
552560
Quarters > 2 > balance Sheet > short Term Debt
49659
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1282966
Quarters > 2 > balance Sheet > equity
3526608
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2834405
Quarters > 2 > cash Flow > depreciation
301
Quarters > 2 > cash Flow > change In Working Capital
-146395
Quarters > 2 > cash Flow > cash From Operations
-2729848
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
4435595
Quarters > 2 > cash Flow > net Change In Cash
1705747
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-7.437977600033589
Quarters > 2 > ratios > PB
0.3392965932136489
Quarters > 2 > ratios > ROE
-80.37198917486718
Quarters > 2 > ratios > ROA
-58.93255826815431
Quarters > 2 > ratios > FCF
-2729848
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
12469180
Quarters > 3 > income Statement > cost Of Revenue
301
Quarters > 3 > income Statement > gross Profit
6234590
Quarters > 3 > income Statement > operating Expenses
2734731
Quarters > 3 > income Statement > operating Income
-2734731
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2728708
Quarters > 3 > income Statement > net Income
-2728708
Quarters > 3 > income Statement > eps
-18.453425306012036
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
147870
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2734430
Quarters > 3 > income Statement > operating Margin
-21.931923350212283
Quarters > 3 > income Statement > total Other Income Expense Net
6023
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1191325
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1873619
Quarters > 3 > balance Sheet > property Plant Equipment
75693
Quarters > 3 > balance Sheet > total Assets
3229289
Quarters > 3 > balance Sheet > payables
880880
Quarters > 3 > balance Sheet > short Term Debt
73020
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1533118
Quarters > 3 > balance Sheet > equity
1696171
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2728708
Quarters > 3 > cash Flow > depreciation
301
Quarters > 3 > cash Flow > change In Working Capital
303154
Quarters > 3 > cash Flow > cash From Operations
-2247721
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
547582
Quarters > 3 > cash Flow > net Change In Cash
-1700139
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-18.453425306012036
Quarters > 3 > ratios > PB
0.2737411499194362
Quarters > 3 > ratios > ROE
-160.87458163121525
Quarters > 3 > ratios > ROA
-84.49872402253251
Quarters > 3 > ratios > FCF
-2247721
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1802621343183754
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
782
Annuals > 0 > income Statement > gross Profit
-782
Annuals > 0 > income Statement > operating Expenses
12051206
Annuals > 0 > income Statement > operating Income
-12051206
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-11850118
Annuals > 0 > income Statement > net Income
-11850118
Annuals > 0 > income Statement > eps
-96.817853524625
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
122396
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-12050424
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
201088
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1191325
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1873619
Annuals > 0 > balance Sheet > property Plant Equipment
75693
Annuals > 0 > balance Sheet > total Assets
3229289
Annuals > 0 > balance Sheet > payables
880880
Annuals > 0 > balance Sheet > short Term Debt
73020
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1533118
Annuals > 0 > balance Sheet > equity
1696171
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11850118
Annuals > 0 > cash Flow > depreciation
782
Annuals > 0 > cash Flow > change In Working Capital
-112404
Annuals > 0 > cash Flow > cash From Operations
-11245042
Annuals > 0 > cash Flow > capital Expenditures
3244
Annuals > 0 > cash Flow > cash From Investing
-3244
Annuals > 0 > cash Flow > cash From Financing
7733414
Annuals > 0 > cash Flow > net Change In Cash
-3514872
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-96.817853524625
Annuals > 0 > ratios > PB
0.2330773725054844
Annuals > 0 > ratios > ROE
-698.6393470941314
Annuals > 0 > ratios > ROA
-366.9574943586653
Annuals > 0 > ratios > FCF
-11248286
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
222
Annuals > 1 > income Statement > gross Profit
-222
Annuals > 1 > income Statement > operating Expenses
11457061
Annuals > 1 > income Statement > operating Income
-11457061
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-11121520
Annuals > 1 > income Statement > net Income
-11121520
Annuals > 1 > income Statement > eps
-211.98787717057735
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
52463
Annuals > 1 > income Statement > income Tax Expense
-2
Annuals > 1 > income Statement > EBITDA
-11456839
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
335541
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4706197
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5632497
Annuals > 1 > balance Sheet > property Plant Equipment
148611
Annuals > 1 > balance Sheet > total Assets
5786643
Annuals > 1 > balance Sheet > payables
311617
Annuals > 1 > balance Sheet > short Term Debt
83649
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
797484
Annuals > 1 > balance Sheet > equity
4989159
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-11121520
Annuals > 1 > cash Flow > depreciation
222
Annuals > 1 > cash Flow > change In Working Capital
605208
Annuals > 1 > cash Flow > cash From Operations
-8063346
Annuals > 1 > cash Flow > capital Expenditures
2776
Annuals > 1 > cash Flow > cash From Investing
-2776
Annuals > 1 > cash Flow > cash From Financing
6268724
Annuals > 1 > cash Flow > net Change In Cash
-1797398
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-211.98787717057735
Annuals > 1 > ratios > PB
0.033964740350026924
Annuals > 1 > ratios > ROE
-222.91372153102355
Annuals > 1 > ratios > ROA
-192.1929519412205
Annuals > 1 > ratios > FCF
-8066122
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
874013
Annuals > 2 > income Statement > gross Profit
-874013
Annuals > 2 > income Statement > operating Expenses
27525431
Annuals > 2 > income Statement > operating Income
-27525431
Annuals > 2 > income Statement > interest Expense
101202
Annuals > 2 > income Statement > pretax Income
-27424229
Annuals > 2 > income Statement > net Income
-27424229
Annuals > 2 > income Statement > eps
-851.1818802569912
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
32219
Annuals > 2 > income Statement > income Tax Expense
27424000
Annuals > 2 > income Statement > EBITDA
-19468793
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
101202
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6503595
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
8386729
Annuals > 2 > balance Sheet > property Plant Equipment
227587
Annuals > 2 > balance Sheet > total Assets
8619851
Annuals > 2 > balance Sheet > payables
327548
Annuals > 2 > balance Sheet > short Term Debt
78896
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1149110
Annuals > 2 > balance Sheet > equity
7470741
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27424229
Annuals > 2 > cash Flow > depreciation
788495
Annuals > 2 > cash Flow > change In Working Capital
543604
Annuals > 2 > cash Flow > cash From Operations
-9605143
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-388843
Annuals > 2 > cash Flow > net Change In Cash
-9993986
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-851.1818802569912
Annuals > 2 > ratios > PB
0.013929993022111193
Annuals > 2 > ratios > ROE
-367.08847221446973
Annuals > 2 > ratios > ROA
-318.15200749989765
Annuals > 2 > ratios > FCF
-9605146
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
875349
Annuals > 3 > income Statement > gross Profit
-875349
Annuals > 3 > income Statement > operating Expenses
12133543
Annuals > 3 > income Statement > operating Income
-12133543
Annuals > 3 > income Statement > interest Expense
362
Annuals > 3 > income Statement > pretax Income
-11958145
Annuals > 3 > income Statement > net Income
-11427534
Annuals > 3 > income Statement > eps
-372.9734651914227
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
30639
Annuals > 3 > income Statement > income Tax Expense
-530611
Annuals > 3 > income Statement > EBITDA
-10775988
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
175398
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
16497581
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
70274
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
18327151
Annuals > 3 > balance Sheet > property Plant Equipment
74181
Annuals > 3 > balance Sheet > total Assets
26463505
Annuals > 3 > balance Sheet > payables
218905
Annuals > 3 > balance Sheet > short Term Debt
71078
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
978405
Annuals > 3 > balance Sheet > equity
25485100
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-11427534
Annuals > 3 > cash Flow > depreciation
790972
Annuals > 3 > cash Flow > change In Working Capital
-1178739
Annuals > 3 > cash Flow > cash From Operations
-8717291
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
9798648
Annuals > 3 > cash Flow > net Change In Cash
1081357
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-372.9734651914227
Annuals > 3 > ratios > PB
0.003883209012324849
Annuals > 3 > ratios > ROE
-44.84005948573873
Annuals > 3 > ratios > ROA
-43.18223908737713
Annuals > 3 > ratios > FCF
-8717291
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.8077512031692444
Valuation > metrics > PB
1.0232460207234026
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-58.9100071688176
Profitability > metrics > ROA
-52.17393614647076
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3001540387253287
Risk > metrics > Interest Coverage
-11590.840531561462
Risk > final Score
-46303
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.058052290242198
Liquidity > metrics > Quick Ratio
9.058052290242198
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-894
Prev Risks > 1
-867
Prev Risks > 2
-1864
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
99
Updated At
2026-01-20T22:22:50.187Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.07
Earnings History > 0 > eps Estimate
-0.45
Earnings History > 0 > eps Difference
0.38
Earnings History > 0 > surprise Percent
84.4444
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.25
Earnings History > 1 > eps Estimate
-0.23
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-8.6957
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.3
Earnings History > 2 > eps Estimate
-1.18
Earnings History > 2 > eps Difference
0.88
Earnings History > 2 > surprise Percent
74.5763
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.74
Earnings History > 3 > eps Estimate
-0.92
Earnings History > 3 > eps Difference
0.18
Earnings History > 3 > surprise Percent
19.5652
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.03
Earnings History > 4 > eps Estimate
-1
Earnings History > 4 > eps Difference
-0.03
Earnings History > 4 > surprise Percent
-3
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.01
Earnings History > 5 > eps Estimate
-0.98
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-3.0612
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.11
Earnings History > 6 > eps Estimate
-1.18
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
5.9322
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.7
Earnings History > 7 > eps Estimate
-1.6
Earnings History > 7 > eps Difference
-0.1
Earnings History > 7 > surprise Percent
-6.25
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.08
Earnings History > 8 > eps Estimate
-0.1
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
20
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.097
Earnings History > 9 > eps Estimate
-0.23
Earnings History > 9 > eps Difference
0.133
Earnings History > 9 > surprise Percent
57.8261
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
35.7143
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.36
Earnings History > 11 > eps Estimate
-0.32
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-12.5
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.37
Earnings History > 12 > eps Estimate
-0.34
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-8.8235
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.32
Earnings History > 13 > eps Estimate
-0.2
Earnings History > 13 > eps Difference
-0.12
Earnings History > 13 > surprise Percent
-60
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.2
Earnings History > 14 > eps Estimate
-0.21
Earnings History > 14 > eps Difference
0.01
Earnings History > 14 > surprise Percent
4.7619
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-30
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.21
Earnings History > 15 > eps Estimate
-0.19
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-10.5263
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-11
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.19
Earnings History > 16 > eps Estimate
-0.18
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-5.5556
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.2
Earnings History > 17 > eps Estimate
-0.14
Earnings History > 17 > eps Difference
-0.06
Earnings History > 17 > surprise Percent
-42.8571
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.14
Earnings History > 18 > eps Estimate
-0.1
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-40
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.69
Earnings History > 19 > eps Estimate
-0.35
Earnings History > 19 > eps Difference
-1.34
Earnings History > 19 > surprise Percent
-382.8571
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.55
Earnings History > 20 > eps Estimate
-0.16
Earnings History > 20 > eps Difference
-0.39
Earnings History > 20 > surprise Percent
-243.75
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-05
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.13
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-15
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.16
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-06
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.23
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-14
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.16
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.18
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-2.718
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-2.2052
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-09-30
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-3.0872
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-06-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-4.6104
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-03-31
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-4.3533
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical trials to treat pancreatic, biliary tract, lung, ovarian, breast, and other cancers; Capecitabine, a combination of PCS6422 and capecitabine, which is in Phase 2 clinical trials to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; and Irinotecan, PCS11T that is in pre-clinical studies to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. It also develops non-oncology drugs consisting of PCS12852 that is in Phase 2B clinical trials for treatment of gastroparesis; and PCS499 for the treatment of glomerular disease. The company has license agreements with Elion Oncology, Inc.; Ocuphire Pharma, Inc.; Aposense, Ltd.; Yuhan Corporation; and CoNCERT Pharmaceuticals, Inc. Processa Pharmaceuticals, Inc. was founded in 2017 and is based in Hanover, Maryland.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow PCSA stock reacts to global recession fears - Watch List & Consistent Profit Trading Strategies bollywoodhelpline.com
Read more →Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV heraldmailmedia.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$25
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.80% of the total shares of Processa Pharmaceuticals Inc
1.
Virtu Financial LLC(0.1876%)
since
2025/06/30
2.
UBS Group AG(0.1158%)
since
2025/06/30
3.
Alpine Partners VI, LLC(0.0957%)
since
2025/06/30
4.
Geode Capital Management, LLC(0.0906%)
since
2025/06/30
5.
Cubist Systematic Strategies, LLC(0.075%)
since
2025/06/30
6.
Fidelity Extended Market Index(0.0524%)
since
2025/07/31
7.
Vanguard Group Inc(0.0438%)
since
2025/06/30
8.
Fidelity Series Total Market Index(0.0374%)
since
2025/07/31
9.
Jane Street Group LLC(0.0345%)
since
2025/06/30
10.
Vanguard Institutional Extnd Mkt Idx Tr(0.0301%)
since
2025/07/31
11.
Sequoia Financial Advisors LLC(0.0197%)
since
2025/06/30
12.
Tower Research Capital LLC(0.0044%)
since
2025/06/30
13.
Northern Trust Extended Eq Market Idx(0.0019%)
since
2025/06/30
14.
NT Ext Equity Mkt Idx Fd - L(0.0019%)
since
2025/06/30
15.
State St US Extended Mkt Indx NL Cl C(0.001%)
since
2025/08/31
16.
Fidelity Total Market Index(0.0008%)
since
2025/07/31
17.
NT Ext Equity Mkt Idx Fd - NL(0.0006%)
since
2025/06/30
18.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0005%)
since
2025/06/30
19.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0004%)
since
2024/12/31
20.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0004%)
since
2025/06/30
21.
SSgA U.S. Total Market Index Strategy(0.0004%)
since
2025/03/31
22.
Wells Fargo & Co(0.0003%)
since
2025/06/30
23.
Bank of America Corp(0.0002%)
since
2025/06/30
24.
State St US Ttl Mkt Indx NL Cl A(0.0001%)
since
2025/08/31
25.
Northern Trust Wilshire 5000(0.0001%)
since
2025/06/30
26.
SBI Securities Co Ltd(0%)
since
2025/06/30
27.
Advisor Group Holdings, Inc.(0%)
since
2025/06/30
28.
Miracle Mile Advisors, INC.(0%)
since
2025/06/30
29.
Armistice Capital, LLC(0%)
since
2025/06/30
30.
HRT FINANCIAL LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.07
EPS Estimate
-0.45
EPS Difference
0.38
Surprise Percent
84.4444%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.